Researchers, manufacturers and patients face the consequences of costly, time-intensive clinical trials, as well as fragmented datasets that widen the evidence gap between clinical research and ultimate treatment success.

Real-world evidence (RWE) is helping bridge that gap by leveraging real-world data (RWD) to generate insights faster and more efficiently, giving power to the patient voice and providing a more in-depth look at how therapeutics perform in real-world settings.

This article examines:

• How to leverage RWD in the clinical development process to improve the quality of clinical outcomes
• ​How to redefine evidence generation to play a larger role in regulatory decision-making, clinical outcome studies and accelerating research advances
• How to engage HEOR and data science expertise to make RWD a core part of clinical and medical strategies for product launch